The Case for GARP: Finding Growth Without the Froth

While market valuations remain on the loftier side, investors face a familiar dilemma. Chasing pure growth leaves portfolios vulnerable to sharp drawdowns, while hiding in traditional "deep value " risks inheriting mature businesses in structural decline — classic value traps. GARP (Growth at a Reasonable Price) sits at the intersection of both styles, offering a disciplined middle ground that pairs double-digit earnings targets with strict valuation caps and quality screens to smooth out market cycles.Key Takeaways
GARP combines double-digit growth with strict valuation caps and quality filters to prevent overpaying for earnings.
SPGP screens S&P 500 growth stocks down to 75 holdings, applying a 5% stock and 40% sector cap.
iShares’ GARP ETF expanded to $3.6B with 54% in its top 15 holdings, while active TCAF reached $8B.
Understanding the Role of PEGPopularized by Peter Lynch, the Price/Earnings-to-Growth (PEG) ratio is widely considered the cornerstone of GARP investing. The PEG ratio divides a stock’s P/E multiple by its expected annual earnings growth. A stock trading at 30 times earnings with 30% expected annual growth carries a PEG of 1.0; ratios below 1.0 are generally viewed as attractive entry points.
While a useful concept, PEG has two key limits:
Forecast Risk: PEG relies on earnings forecasts that are notoriously unreliable. Analyst optimism and temporary hyper-growth can make a stock look cheap on consensus until growth normalizes. Instead, PEG ought to be evaluated alongside free cash flow, ROE, and balance sheet stability.
Methodology Mismatch: Most GARP ETFs do not use forward PEG at all. The Invesco S&P 500 GARP Index, for example, ranks stocks on trailing three-year growth in earnings-to-price and sales-to-price, screening the top half for leverage, ROE, and P/E. Trailing metrics avoid forecasting bias but introduce trade-offs when macro conditions shift.
Why GARP Is Getting AttentionAfter years of tech-driven gains, growth has become expensive. The Russell 1000 Growth Index trades at approximately 33.5 times trailing earnings versus 20.5 times for value, a premium of about 1.64 times against a historical median of about 1.43 times since 2000.
GARP offers a way to bridge the gap by mitigating four market risks:
Valuation risk. GARP screens aim to keep growth exposure while filtering out the richest multiples. Maintains secular growth exposure while stripping out speculative multiples that earnings cannot support.
Concentration risk. Cap-weighted growth benchmarks have become top-heavy. GARP methodology screens can spread capital more broadly across sectors depending on the rules-based weighting mechanism in place.
Value traps. Requiring robust earnings growth and quality screens filters out many structurally declining businesses that weigh on pure value indexes.
Late-cycle resilience. When economic growth cools, durable earners (10%-20% EPS growth) with high ROE and manageable debt may hold up better, providing downside cushion during corrections (though GARP may lag during narrow, momentum-led rallies).
Mapping the GARP ETF LandscapePureplay GARP ETFs remain relatively scarce in the U.S. marketplace. While many smart-beta products incorporate light quality or value overlays, only a few explicitly track dedicated GARP indexes — alongside select active managers operating with a GARP mandate.
Invesco S&P 500 GARP ETF SPGP: The longest running pureplay GARP ETF anchors the space with more than $2 billion in assets, while charging an expense ratio of 0.36%. SPGP isolates the 150 top growth S&P 500 names and screens down to the top 75 based on quality and value scores. Holdings are growth-weighted with a 5% stock cap and 40% sector limit, offering value-conscious diversification alongside mid-cap (Invesco S&P MidCap 400 GARP ETF GRPM) and small-cap (Invesco S&P SmallCap 600 GARP ETF GRPZ) sister funds.
iShares MSCI USA Quality GARP ETF GARP: BlackRock’s primary GARP vehicle focuses on U.S. large- and mid-cap equities exhibiting favorable value and quality characteristics relative to their growth prospects. Launched in January 2020 with a 0.15% expense ratio, the 148-stock fund carries a pronounced growth-and-quality tilt. Its portfolio is top-heavy, with tech accounting for more than half of all assets and the top 15 holdings representing roughly 54%. Backed by strong momentum — up over 20% on a NAV basis with $2.1 billion in year to date net inflows — GARP has expanded its total asset base to $3.6 billion.
T. Rowe Price Capital Appreciation Equity ETF TCAF: Managed by David Giroux, TCAF applies a systematic quality-growth framework with a strict GARP tilt — focusing on free cash flow compounders with valuation discipline. TCAF’s assets have quickly swelled to $8 billion as investors seek active risk control.
The Bottom LineGARP offers systematic growth participation at a time when equity valuations and macro risks remain elevated. Advisors should perhaps treat the PEG ratio as a starting point rather than a sole filter, prioritize self-funded secular growth and evaluate GARP funds by their underlying index rules and weighting schemes. Positioned as a core holding alongside growth and value sleeves, GARP captures structural upside while managing what investors pay for it.
For more news, information, and analysis, visit the Equity ETF Content Hub.
Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.
ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.
For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.
FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.
News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.
Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.
Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.